Skip to main content
. 2024 Oct 12;25(20):10991. doi: 10.3390/ijms252010991

Table 2.

Microbiome-induced inflammation is associated with PDAC via multiple pathways with several proinflammatory factors.

Type Microbiome Functions in PDAC
Microbial dysbiosis P. gingivalis
  • A critical role in initiating inflammation and escaping the immune response related to lipopolysaccharide (LPS) and toll-like receptors (TLRs)

Fusobacterium
  • Fusobacterium could increase the production of ROS and inflammatory cytokines, and modulate the tumor immune microenvironment

Helicobacter pylori
  • The Helicobacter pylori IgG level was higher in PDAC

  • Helicobacter pylori may promote the development of PDAC by causing chronic mucosal inflammation as well as changes in cell proliferation and differentiation.

Hepatotropic viruses
HBV and HCV
  • HBsAg and HBcAg were found in the cytoplasm of pancreatic acinar cells

  • Inflammation and modifying tissue viscoelasticity, DNA integration in infected cells that delay host immune system clearance of HBV/ HCV-containing cells

  • Modulating the PI3K/AKT signaling pathway via the HBV/HCV protein

Gammaproteobacteria
Bifidobacterium pseudolongum
  • The pancreas is not sterile and has its own microbial environment which may affect the occurrence and development of PDAC.

  • Gammaproteobacteria might modulate tumor sensitivity to gemcitabine.

Other: Fungi and viruses
  • Oncogenic Kras-induced inflammation leads to fungal dysbiosis, which in turn promotes tumor progression via activation of the MBL-C3 cascade.

  • The fungal microbiome drives a KrasG12D-MEK signaling pathway in PDAC cells that promotes the secretion of a pro-inflammatory cytokine, IL-33, which can subsequently hasten the spread of PDAC by secreting pro-tumorigenic cytokines such as IL-4, IL-5, and IL-13.

Microbial metabolites lipopolysaccharide (LPS)
  • A Gram-negative bacterial cell wall component

  • LPS can interact with several TLRs signaling pathways leading to T-cell anergy.

  • LPS-TLR signaling can activate NF-κB, MAPK, the signal transducers and activators of STAT3 signaling pathway and trigger mutation of KRAS

deoxycholic acid (DCA) and short-chain fatty acids (SCFAs)
  • They both promote intestinal tumorigenesis in conjunction with adenomatous polyposis coli (Apc) gene mutation

  • Causing DNA damage, modulating the inflammatory cytokines and chemokines expressing in the PDAC TME via activation of Wnt signaling which is important for cell proliferation during tumorigenesis.

  • DCA can activate the epidermal growth factor receptor (EGFR)